Eubel Brady & Suttman Asset Management Inc Invitae Corp Transaction History

Eubel Brady & Suttman Asset Management Inc

  • $786 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$24.31 - $33.6 $1,507 - $2,083
-62 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$26.09 - $40.4 $1,617 - $2,504
62 New
62 $2,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Eubel Brady & Suttman Asset Management Inc Portfolio

Follow Eubel Brady & Suttman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email